Researcher wins Alzheimer's disease drug discovery award

(Boston University Medical Center) Research that leads to improved therapies for Alzheimer's disease patients is one goal of Boston University School of Medicine professor of pharmacology and neurology Benjamin Wolozin, M.D., Ph.D. He was one of six researchers awarded a two-year, $500,000 award in Alzheimer's Disease Drug Discovery Research by the Edward N. & Della L. Thome Memorial Foundation.